This randomized, single-blind, parallel-group controlled trial aims to investigate the effects of expiratory muscle training added to standard pulmonary rehabilitation on respiratory muscle strength, pulmonary function, cough effectiveness, exercise capacity, dyspnea perception, and quality of life in patients with non-cystic fibrosis bronchiectasis. Eligible patients aged 18-70 years with stable disease will be randomly assigned to either a pulmonary rehabilitation-only group or a pulmonary rehabilitation combined with expiratory muscle training group. Outcomes will be assessed at baseline and after completion of the intervention period.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Functional capacity
Timeframe: Baseline and 8 weeks
Maximum Inspiratory Pressure (MIP)
Timeframe: Baseline and 8 weeks
Maximum Expiratory Pressure (MEP)
Timeframe: Baseline and 8 weeks
Forced Vital Capacity (FVC)
Timeframe: Baseline and 8 weeks
Forced Expiratory Volume in 1 Second (FEVā)
Timeframe: Baseline and 8 weeks
FEVā/FVC Ratio
Timeframe: Baseline and 8 weeks
Cough Strength (Peak Cough Flow, PCF)
Timeframe: Baseline and 8 weeks
reyhan kaygusuz benli, Assist Prof